Related Experiment Video
Updated: Oct 12, 2025

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment
Published on: June 28, 2018
Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development
Anna Valeria Samarelli1,2, Valentina Masciale1,3, Beatrice Aramini1,4
1Laboratory of Cell Therapies and Respiratory Medicine, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena and Reggio Emilia, 41100 Modena, Italy.
Idiopathic pulmonary fibrosis (IPF) and lung cancer (LC) share common molecular pathways. Understanding these shared mechanisms may reveal new therapeutic targets for treating both IPF and LC.
Area of Science:
- Pulmonology
- Oncology
- Molecular Biology
Background:
- Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with poor prognosis.
- Risk factors like smoking and environmental exposures are linked to IPF.
- IPF and lung cancer (LC) share common risk factors and molecular pathways.
Purpose of the Study:
- To review current research on shared cellular and molecular mechanisms between IPF and LC.
- To identify potential therapeutic targets for combined IPF and LC treatment.
Main Methods:
- Literature review of studies on IPF and LC.
- Analysis of common cellular processes (e.g., fibroblast activation, stress responses).
- Examination of shared molecular and genetic markers.
Main Results:
- IPF and LC share pathways including fibroblast proliferation, endoplasmic reticulum stress, and oxidative stress.
- Genetic and epigenetic factors contribute to the predisposition of IPF patients to LC.
- Nintedanib, a tyrosine-kinase inhibitor, highlights the link between anti-cancer and anti-fibrotic pathways.
Conclusions:
- Shared molecular mechanisms provide a basis for novel therapeutic strategies.
- Targeting common pathways could simultaneously address IPF and LC.
- Further research into these shared mechanisms is crucial for developing effective treatments.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Prevention
Some...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

